SAN
FRANCISCO, Nov. 6, 2024 /PRNewswire/ -- Nektar
Therapeutics (Nasdaq: NKTR) today announced that the
company will be webcasting its participation in the upcoming
conferences:
- UBS Global Healthcare Conference in Rancho Palos Verdes,
CA on Wednesday, November 13, 2024 at
1:15 p.m. Eastern Time / 10:15 a.m. Pacific Time – webcast link here
- Piper Sandler 36th Annual Healthcare Conference
in New York, NY on Wednesday, December 4, 2024 at 1:00 p.m. Eastern Time / 4:00 p.m. Pacific Time – webcast link here
The presentations will be accessible via the webcast links above
as well as on the Investor Events section of the Nektar website:
https://ir.nektar.com/events-and-presentations/events. Replays of
the presentations will be available for 30 days.
If you would like to request a one-on-one meeting with company
management during the conferences, please reach out to your
respective bank representative.
About Nektar Therapeutics
Nektar Therapeutics is a clinical-stage biotechnology company
focused on developing treatments that address the underlying
immunological dysfunction in autoimmune and chronic inflammatory
diseases. Nektar's lead product candidate, rezpegaldesleukin
(REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell
stimulator being evaluated in two Phase 2b clinical trials, one in atopic dermatitis and
one in alopecia areata. Our pipeline also includes a preclinical
candidate NKTR-0165, which is a bivalent tumor necrosis factor
receptor type II agonist antibody. Nektar, together with various
partners, is also evaluating NKTR-255, an investigational IL-15
receptor agonist designed to boost the immune system's natural
ability to fight cancer, in several ongoing clinical trials. Nektar
is headquartered in San Francisco,
California. For further information, visit www.nektar.com
and follow us on LinkedIn.
Contact:
For Investors:
Vivian Wu
Nektar Therapeutics
628-895-0661
For Media:
Madelin Hawtin
LifeSci Communications
603-714-2638
mhawtin@lifescicomms.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nektar-therapeutics-to-participate-in-upcoming-investor-conferences-302297943.html
SOURCE Nektar Therapeutics